This project is a continuing series of translational clinical trials evaluating novel analgesic strategies and therapeutic agents with potential for enhanced efficacy and safety in comparison to standard treatments. Specific objectives of this project are: 1) to evaluate the analgesic potential of investigational analgesics which alter either the synthesis or receptor activation of inflammatory and neuroendocrine mediators; 2) to develop novel analgesic strategies for preventing pain and optimizing analgesia while minimizing side effect potential for acute pain in ambulatory patients; and 3) to characterize the neuroendocrine responses to surgical stress, acute pain, and inflammation. Subjects in these investigations undergo oral surgery performed with local anesthesia with resultant neuroendocrine responses to pain and surgical stress during the perioperative period as well as acute pain for several days. Samples are collected from blood to evaluate systemic responses, by microdialysis at the extraction site to measure local release of inflammatory mediators such as prostaglandins, and by tissue biopsy to measure cellular changes due to inflammation. Subjects remain at the clinic up to eight hours postoperatively and may return at 24 and 48 hours for additional observations. Results of recent studies demonstrate the efficacy of preventive strategies which decrease nociceptive input during the immediate postoperative period, have differentiated peripheral from systemic effects for prototypic analgesic drugs, and evaluated the efficacy of novel analgesic mechanisms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Intramural Research (Z01)
Project #
1Z01DE000286-21
Application #
6432001
Study Section
(PNMB)
Project Start
Project End
Budget Start
Budget End
Support Year
21
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Dental & Craniofacial Research
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Wang, Xiao-Min; Wu, Tian-Xia; Hamza, May et al. (2007) Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain 128:136-47
Dworkin, Robert H; Turk, Dennis C; Farrar, John T et al. (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113:9-19
Warburton, Gary; Nares, Salvador; Angelov, Nikola et al. (2005) Transcriptional events in a clinical model of oral mucosal tissue injury and repair. Wound Repair Regen 13:19-26
Lee, Y; Rodriguez, C; Dionne, R A (2005) The role of COX-2 in acute pain and the use of selective COX-2 inhibitors for acute pain relief. Curr Pharm Des 11:1737-55
Dionne, Raymond A; Bartoshuk, Linda; Mogil, Jeffrey et al. (2005) Individual responder analyses for pain: does one pain scale fit all? Trends Pharmacol Sci 26:125-30
Dionne, Raymond A; Haynes, Duncan; Brahim, Jaime S et al. (2004) Analgesic effect of sustained-release flurbiprofen administered at the site of tissue injury in the oral surgery model. J Clin Pharmacol 44:1418-24
Ta, Lauren E; Dionne, Raymond A (2004) Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen. Pain 111:13-21
Kim, Hyungsuk; Neubert, John K; San Miguel, Anitza et al. (2004) Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain 109:488-96
Phero, James C; Becker, Daniel E; Dionne, Raymond A (2004) Contemporary trends in acute pain management. Curr Opin Otolaryngol Head Neck Surg 12:209-16
Gordon, Sharon M; Dionne, Raymond A (2004) The integration of clinical research into dental therapeutics: the role of the astute clinician. J Am Dent Assoc 135:1537-42

Showing the most recent 10 out of 20 publications